Predictive Value of Lidocaine for Treatment Success of Oxcarbazepine in Patients with Neuropathic Pain Syndrome

Predictive Value of Lidocaine for Treatment Success of Oxcarbazepine in Patients with Neuropathic Pain Syndrome

Bibliographic Details
Main Authors:	Schipper, Sivan, Gantenbein, Andreas R., Maurer, Konrad, Alon, Eli, Sándor, Peter S.
Format:	Online
Language:	English
Published:	Springer Healthcare 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107880/

Similar Items

Can treatment success with 5% lidocaine medicated plaster be predicted in cancer pain with neuropathic components or trigeminal neuropathic pain?
by: Kern, Kai-Uwe, et al.
Published: (2013)

Effect of Intravenous Lidocaine on the Neuropathic Pain of Failed Back Surgery Syndrome
by: Park, Chan Hong, et al.
Published: (2012)

5% Lidocaine-medicated plaster for the treatment of chronic peripheral neuropathic pain: complex regional pain syndrome and other neuropathic conditions
by: Calderón, Enrique, et al.
Published: (2016)

Prevalence of medication overuse headache in an interdisciplinary pain clinic
by: Schmid, Corinne Wanner, et al.
Published: (2013)

Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain
by: Di Stefano, Giulia, et al.
Published: (2014)

Transdermal Lidocaine and Ketamine for Neuropathic Pain: A Study of Effectiveness and Tolerability
by: Tam, Emily, et al.
Published: (2012)

Treatment of Neuropathic Pain with the Capsaicin 8% Patch: Is Pretreatment with Lidocaine Necessary?
by: Kern, Kai-Uwe, et al.
Published: (2014)

Genetic predisposition to oxcarbazepine induced Stevens–Johnson syndrome
by: Wal, Pranay, et al.
Published: (2011)

Uncontrolled headache induced by oxcarbazepine
by: Piovesan, Elcio Juliato, et al.
Published: (2007)

Oxcarbazepine-induced Stevens Johnson syndrome: A rare case report
by: Sharma, S. R., et al.
Published: (2011)

606 Case Report: Hypogammaglobulinemia Induced by Oxcarbazepine
by: Marinovic, Maria Angelica, et al.
Published: (2012)

Effect of Oxcarbazepine on Background EEG Activity and Cognition in Epilepsy
by: Kim, Sung Min, et al.
Published: (2013)

Cutaneous adverse drug reactions induced by Oxcarbazepine
by: Hsiao, Yi-Hsin, et al.
Published: (2014)

Intrathecal lidocaine pretreatment attenuates immediate neuropathic pain by modulating Nav1.3 expression and decreasing spinal microglial activation
by: Cheng, Kuang-I, et al.
Published: (2011)

Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician
by: Hans, Guy, et al.
Published: (2010)

Treatment of localized post-traumatic neuropathic pain in scars with 5% lidocaine medicated plaster
by: Correa-Illanes, Gerardo, et al.
Published: (2010)

Treatment of localized neuropathic pain after disk herniation with 5% lidocaine medicated plaster
by: Likar, Rudolf, et al.
Published: (2012)

Use of 5% lidocaine medicated plaster to treat localized neuropathic pain secondary to traumatic injury of peripheral nerves
by: Correa-Illanes, Gerardo, et al.
Published: (2012)

Building a diagnostic algorithm on localized neuropathic pain (LNP) and targeted topical treatment: focus on 5% lidocaine-medicated plaster
by: Casale, Roberto, et al.
Published: (2014)

The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence
by: de León-Casasola, Oscar A, et al.
Published: (2016)

The lidocaine metabolite N-ethylglycine has antinociceptive effects in experimental inflammatory and neuropathic pain
by: Werdehausen, Robert, et al.
Published: (2015)

5% lidocaine medicated plaster double effect in a case of orofacial localized neuropathic pain
by: Casale, Roberto, et al.
Published: (2014)

Treatment of localized neuropathic pain of different etiologies with the 5% lidocaine medicated plaster – a case series
by: Likar, Rudolf, et al.
Published: (2014)

Neuropathic pain
by: Khan, Junad
Published: (2016)

Reduction of painful area as new possible therapeutic target in post-herpetic neuropathic pain treated with 5% lidocaine medicated plaster: a case series
by: Casale, Roberto, et al.
Published: (2014)

Treatment of interstitial cystitis/painful bladder syndrome as a neuropathic pain condition
by: Vas, Lakshmi, et al.
Published: (2014)

Titrimetric and Spectrophotometric Assay of Oxcarbazepine in Pharmaceuticals Using N-Bromosuccinimide and Bromopyrogallol Red
by: Rajendraprasad, Nagaraju, et al.
Published: (2011)

May Long Term Oxcarbazepine Treatment Be Lead to Secondary Hyperparathyroidism?
by: Babacan, O., et al.
Published: (2012)

Oxcarbazepine induced toxic epidermal necrolysis - a rare case report
by: Guleria, Vivek S., et al.
Published: (2015)

EHMTI-0355. Comparison of carbamazepine and oxcarbazepine tolerability in patients with trigeminal neuralgia
by: Cregg, R, et al.
Published: (2014)

Oxcarbazepine – induced hyponatremia in bipolar disorder: A report of two cases
by: Kumar, Pattath Narayanan Suresh, et al.
Published: (2016)

Systemic Ropivacaine Diminishes Pain Sensitization Processes: A Randomized, Double-Blinded, Placebo-Controlled, Crossover Study in Healthy Volunteers
by: Haller, Yéri, et al.
Published: (2014)

The importance of catastrophizing for successful pharmacological treatment of peripheral neuropathic pain
by: Toth, Cory, et al.
Published: (2014)

Hydromorphone for neuropathic pain in adults
by: Stannard, Cathy, et al.
Published: (2016)

Fentanyl for neuropathic pain in adults
by: Derry, Sheena, et al.
Published: (2016)

Buprenorphine for neuropathic pain in adults
by: Wiffen, Philip J., et al.
Published: (2015)

Role of Neurotrophins in Neuropathic Pain
by: Siniscalco, Dario, et al.
Published: (2011)

Neuronal mechanism for neuropathic pain
by: Zhuo, Min
Published: (2007)

Neuropathic pain in hereditary coproporphyria
by: Chen, Guan-Liang, et al.
Published: (2013)

Ocular neuropathic pain
by: Rosenthal, Perry, et al.
Published: (2016)